ERBB2 and neoplasm: Various clinical parameters and molecular biomarkers, such as age, Body Mass Index (BMI), tumor stage, histological type, hormone receptor, HER2 status and Ki-67 expression level, have been correlated with a pCR [3, 4, 16].